In particular, 5hmC is significantly downregulated in gliomas, which may be attributed to a mutation in the isocitrate dehydrogenase genes IDH1/2, resulting in either a shortage of TET or the TET cosubstrate α-ketoglutaric acid. Here, IDH1 is linked to central nervous system cancer.